| 篇序 | 作者姓名 (順位) |
論文題目/發表雜誌名稱 | 發表學會或會議名稱 | 地點 |
|---|---|---|---|---|
| 1 | 孫啟書 | Case sharing: 76 y/o man, with CAD, acute cholecystitis s/p PTGBD, with duodenal diverticulum, s/p ERCP + fistulotomy, complicated with retroperitoneal perforation, finally with PTGBD conversion into ETGBD | The 5th south ERCP forum | 台南 |
| 2 | 馮意哲(C) | Long-term biomarker evaluation and clinical relevance of oxidative stress in chronic hepatitis C patients receiving direct acting antivirals | 2020 Taiwan Digestive Disease Week (TDDW) | 台北 |
| 3 | 馮意哲(C) | Announcement of Hosting of Virtual & On-site Congress | Asian Organization for Crohn’s Colitis 8th(AOCC 2020) | 韓國 |
| 4 | 馮意哲(4) | Real-world effectiveness and safety of vedolizumab therapy for inflammatory bowel disease in Taiwan: Results from the TSIBD registry (VIOLET Study) | Asian Organization for Crohn’s Colitis 8th(AOCC 2020) | 韓國 |
| 5 |
陳季杏(1) |
Recurrence rate of neoplasms after underwater endoscopic mucosal resection (UEMR) 大腸鏡水下內視鏡黏膜切除術後之腫瘤復發狀況 |
2020 Taiwan Digestive Disease Week (TDDW) | 台北 |
| 6 |
陳建宏(1) |
Vedolizumab versus Adalimumab for Crohn's disease: a single-center experience of Southern Taiwan | 110年消化系聯合學術演講年會 | 台中 |
| 7 |
王宿鴻(1) |
Clinical Value of Serum CA19-9 and CEA as a diagnostic and prognostic Factor for Ampulla of Vater Carcinoma. Experience from a single medical center in Taiwan | 2020 台灣消化醫學週Taiwan Digestive Disease Week (TDDW) | 台北 |
| 8 |
張峻愷(1) |
The rate of relapse in IBD patients after cessation of Vedolizumab:A retrospective study in a single medical center | 110年消化系聯合學術演講年會 | 台中 |
| 9 |
黃懷毅(1) |
Moderate to Severe IBD cases receiving Biologics therapy- an experience in a single medical center of Southern Taiwan | 2020 Taiwan Digestive Disease Week | 台北 |
| 10 |
黃懷毅(1) |
A case report of gastrointestinal tract Kaposi sarcoma | 消化系醫學會第275次學術討論月會 | 台南 |
| 11 |
黃懷毅(1) |
A case report of post bariatric surgery with clinical intussusception | 第94次電子內視鏡病例暨併發症討論會 | 台北 |
